Macrolides and phagocytosis
Samsygina, G.A.
Antibiotiki i Khimioterapiia 44(2): 33-36
1999
ISSN/ISBN: 0235-2990 PMID: 10202556 Document Number: 509471
Document emailed within 1 workday
Related Documents
Rolin, O.; Bouanchaud, D.H. 1989: Comparison of the in vitro post-antibiotic effect of C14 macrolides (erythromycin and roxithromycin) and C16 macrolides (josamycin and spiramycin) against Staphylococcus aureus Pathologie-Biologie 37(5): 375-377Melezyńska-Matej, M.; Grzybek-Hrynewicz, K.; Kotlarek-Haus, S.; Kaiser, A. 1981: Studies on phagocytosis in leukaemia. III. Phagocytosis inhibiting factor in sera of leukaemic patients Folia Haematologica 108(4): 559-566
Carmel, N.; Markus, R.; Gross, J.; Stern, K. 1972: Reticuloendothelial phagocytosis of Cr 51 -labeled sheep red cells in mice. II. Effects of lipopolysaccharide on phagocytosis and hemopexin levels Israel Journal of Medical Sciences 8(11): 1783-1790
Chang, Y.H. 1972: Studies on phagocytosis. II. The effect of nonsteroidal anti-inflammatory drugs on phagocytosis and on urate crystal-induced canine joint inflammation Journal of Pharmacology and Experimental Therapeutics 183(1): 235-244
Ohtami, H.; Nakase, A.; Kawai, S. 2003: Macrolides Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 2): 744-749
Endou, K.; Nakajima, Y. 1997: Resistance to macrolides Nihon Rinsho. Japanese Journal of Clinical Medicine 55(5): 1238-1244
De Marino, V.; Marino, A. 1988: Macrolides: a critical re-evaluation La Clinica Terapeutica 127(2): 91-98
Mensa, J.é; García-Vázquez, E.; Vila, J. 2003: Macrolides, ketolides and streptogramins Enfermedades Infecciosas y Microbiologia Clinica 21(4): 200-207; Quiz 208, 219
Oishi, K. 2000: Tracheal neutrophils and macrolides Japanese Journal of Antibiotics 53 Suppl A: 99-102
Guo, D.; Cai, Y.; Chai, D.; Liang, B.; Bai, N.; Wang, R. 2010: The cardiotoxicity of macrolides: a systematic review Die Pharmazie 65(9): 631-640
2003: Telithromycin: new preparation. A needless addition to the other macrolides Prescrire International 12(63): 8-11
Shafran, S.D.; Conley, J.M. 1997: Does Chlamydia pneumoniae cause coronary atherosclerosis and should we all take macrolides? Canadian Journal of Cardiology 13(11): 1017-1019
Millesimo, M.; Savoia, D. 1995: Group A streptococci: evaluation of in vitro resistance to two macrolides Microbios 82(332): 141-147
Kyo, S.; Tamaoki, J.; Kondo, M.; Isono, K.; Nagai, A. 1998: Effects of macrolides on intracellular Ca2+ response by airway epithelium Japanese Journal of Antibiotics 51 Suppl A: 155-157
Bochet, M.él.; Garin, N.; Janssens, J.-P.; Gerstel, E. 2011: Is there a role for prophylactic antibiotic treatment with macrolides in bronchiectasis? Revue Medicale Suisse 7(280): 308; 310-312
Alonso Manzanares, M.A.; Gutíerrez Zufiaurre, M.N.; Muñoz Bellido, J.L.; García-Rodríguez, J.A. 1998: Resistance to macrolides, lincosamides and streptogramins in infections by Streptococcus pneumoniae Medicina Clinica 110 Suppl. 1: 25-30
Lin, J.T.; Zhang, Y.M.; Zhou, X.; Wang, C.Z.; Huang, M.; Liu, C.T.; Wu, C.G.; Wan, H.Y.; Yu, W.C.; Dai, Y.R. 2017: Chinese expert consensus for non-antiinfective effects and clinical use of macrolides Zhonghua Nei Ke Za Zhi 56(7): 546-557
Khrianin, A.A.; Reshetnikov, O.V. 2010: Use of macrolides in pregnancy and lactation according to evidence-based medicine: pro et contra Antibiotiki i Khimioterapiia 55(9-10): 50-56
Płusa, T. 2008: Clinical basis of macrolides apply in diseases of the respiratory tract Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 25(149): 432-436
Yamaya, M.; Suzuki, T.; Asada, M.; Sasaki, T.; Nishimura, H. 2007: New findings on the biological activities of macrolides--antiviral effects of macrolide antibiotics Nihon Rinsho. Japanese Journal of Clinical Medicine 65 Suppl 2(Part 1): 679-682